MLL2/KMT2D and MLL3/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia
D. Rabello, Vivian D'Afonseca da Silva Ferreira, M. G. Berzoti-Coelho, S. Burin +6 more
2018Cancer Cell International28 citations Open access
Semantic Scholar

